Osteal Therapeutics
Dallas, TX · Healthcare, Health Care, Other · 49 employees
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
Funding history
- Venture - Series Unknown — $15.6M — Nov 2025
- Venture - Series Unknown — $50.0M — Jun 2024
- Series C — $23.0M — Sep 2023
- Venture - Series Unknown — $22.3M — Sep 2023
- Series B — $30.0M — Mar 2022
Recent signals
- Nov 05, 2025: Raised $15.6M in Venture - Series Unknown
- Jun 06, 2024: Raised $50.0M in Venture - Series Unknown
- Sep 21, 2023: Raised $23.0M in Series C
- Sep 12, 2023: Raised $22.3M in Venture - Series Unknown
- Mar 08, 2022: Raised $30.0M in Series B
- Jan 26, 2022: Raised $2.0M in Pre-Seed
- Jan 12, 2021: Raised $2.0M in Venture - Series Unknown
- Nov 23, 2020: Raised $1.5M in Seed
See plans & pricing → Track Osteal Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.